STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended		71 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (956,798)	$ (1,516,309)	$ (5,848,906)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	32,782	32,500	168,198
Change in allowance for uncollectible notes receivable		13,867	38,867
Amortization of deferred finance costs	26,114	1,252	59,605
Amortization of debt discount	2,220		2,220
Interest expense on fair value adjustments of convertible notes payable	202,424	59,280	450,353
Write-off of uncollectible deposit			20,000
Accrued interest on notes receivable			(11,705)
Loss on extinguishment of debt	37,197	297,796	381,113
Loss on impairment	21,800	21,000	42,800
Stock issued for services	125,887	561,277	1,833,856
Stock issued to satisfy legal services	25,754	40,557	65,494
Stock issued for financing fees	1,500	3,500	5,000
Changes in operating assets and liabilities:
Prepaid expenses	(4,400)	(43,860)	(48,260)
Advances from shareholder	(1,015)		(1,015)
Deposits and other receivables			(23,346)
Accounts payable and accrued liabilities	(13,284)	33,960	232,201
Net cash used in operating activities	(499,819)	(495,180)	(2,633,525)
CASH FLOWS FROM INVESTING ACTIVITIES
Principal payments from notes receivable			(25,000)
Purchase of common stock	(12,000)	(21,000)	(34,100)
Acquisition of equipment			(325,000)
Net cash used in investing activities	(12,000)	(21,000)	(384,100)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from the issuance of common stock	258,400	297,172	2,047,544
Proceeds from the issuance of convertible notes payable	249,500	95,000	762,800
Proceeds from the issuance of convertible notes payable, related parties	50,000		56,000
Proceeds from the issuance of notes payable	10,000	160,000	286,500
Proceeds from the issuance of notes payable, related parties	2,500	6,000	8,500
Payments on convertible notes payable	(11,000)	(25,000)	(46,000)
Payments on notes payable	(12,500)	(5,000)	(57,500)
Payments on notes payable, related parties		(1,000)	(1,000)
Proceeds on loans from stockholders	5,000		40,925
Payments on stockholder loans	(5,000)	(5,225)	(36,225)
Net cash provided by financing activities	546,900	521,947	3,061,544
CHANGE IN CASH	35,081	5,767	43,919
CASH, BEGINNING OF PERIOD	8,838	3,071
CASH, ENDING OF PERIOD	43,919	8,838	43,919
NONCASH OPERATING AND FINANCING ACTIVITIES:
Due to Organetix, Inc. reclassified to additional paid-in capital			91,500
Common stock issued to satisfy minimum value guarantee			87,667
Common stock issued to satisfy debt	76,528		76,528
Convertible debt converted to common stock including accrued interest	259,986	540,524	1,238,248
Common stock issued in exchange for a fixed asset	7,420		7,420
Common stock issued in conjunction with a joint venture	9,800		9,800
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for Interest			$ 3,660